ArticleJournal for immunotherapy of cancer2024

FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription.

Xuemei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.